No Undisclosed Events or Circumstances. Except as disclosed in the SEC Documents, since December 31, 2023, except for the consummation of the transactions contemplated herein, to the Company’s knowledge, no event or circumstance has occurred or exists with respect to the Company or its businesses, properties, prospects, operations or financial condition, which, under applicable law, rule or regulation, requires public disclosure or announcement by the Company but which has not been so publicly announced or disclosed.
Appears in 5 contracts
Sources: Common Stock Purchase Agreement (Exicure, Inc.), Common Stock Purchase Agreement (Exicure, Inc.), Common Stock Purchase Agreement (Exicure, Inc.)
No Undisclosed Events or Circumstances. Except as disclosed in the SEC Documents, since December 31, 2023, and except for the consummation of the transactions contemplated herein, since June 30, 2017, to the Company’s knowledge, no event or circumstance has occurred or exists with respect to the Company or its businesses, properties, prospects, operations or financial condition, which, under applicable law, rule or regulation, requires public disclosure or announcement by the Company but which has not been so publicly announced or disclosed.
Appears in 3 contracts
Sources: Debt Conversion Agreement (Oragenics Inc), Securities Purchase Agreement (Oragenics Inc), Share Purchase Agreement (Synthetic Biologics, Inc.)
No Undisclosed Events or Circumstances. Except as disclosed in the SEC Commission Documents, since December 31, 20232009, except for the consummation of the transactions contemplated herein, to the Company’s knowledge, no event or circumstance has occurred or exists with respect to the Company or its businesses, properties, prospects, operations or financial condition, which, under applicable law, rule or regulation, requires public disclosure or announcement by the Company but which has not been so publicly announced or disclosed.
Appears in 3 contracts
Sources: Stock Purchase Agreement (Intrexon Corp), Stock Purchase Agreement (Intrexon Corp), Stock Purchase Agreement (Ziopharm Oncology Inc)
No Undisclosed Events or Circumstances. Except as disclosed in the SEC Documents, since December 31September 30, 20232022, except for the consummation of the transactions contemplated herein, to the Company’s knowledge, no event or circumstance has occurred or exists with respect to the Company or its businesses, properties, prospects, operations or financial condition, which, under applicable law, rule or regulation, requires public disclosure or announcement by the Company but which has not been so publicly announced or disclosed.
Appears in 2 contracts
Sources: Securities Purchase Agreement (Taysha Gene Therapies, Inc.), Securities Purchase Agreement (Landos Biopharma, Inc.)
No Undisclosed Events or Circumstances. Except as disclosed in the SEC Disclosure Documents, since December 31, 20232020, except for the consummation of the transactions contemplated herein, to the Company’s knowledge, no event or circumstance has occurred or exists with respect to the Company or its businesses, properties, prospects, operations or financial condition, which, under applicable law, rule or regulation, requires public disclosure or announcement by the Company but which has not been so publicly announced or disclosed.
Appears in 2 contracts
Sources: Securities Purchase Agreement (Assure Holdings Corp.), Securities Purchase Agreement (Assure Holdings Corp.)
No Undisclosed Events or Circumstances. Except as disclosed in the SEC Documents, since December March 31, 20232012, except for the consummation of the transactions contemplated herein, to the Company’s knowledge, no event or circumstance has occurred or exists with respect to the Company or its businesses, properties, prospects, operations or financial condition, which, under applicable law, rule or regulation, requires public disclosure or announcement by the Company but which has not been so publicly announced or disclosed.
Appears in 2 contracts
Sources: Stock Issuance Agreement, Stock Issuance Agreement (Synthetic Biologics, Inc.)
No Undisclosed Events or Circumstances. Except as disclosed in the SEC Documents, since December 31, 2023, except for the consummation of the transactions contemplated herein, to the Company’s knowledge, no event or circumstance has occurred or exists with respect to the Company or its businesses, properties, prospects, operations or financial condition, which, under applicable law, rule or regulation, requires public disclosure or announcement by the Company Company, or which would cause a Material Adverse Effect, but which has not been so publicly announced or disclosed.
Appears in 2 contracts
Sources: Securities Purchase Agreement (Lazydays Holdings, Inc.), Securities Purchase Agreement (Lazydays Holdings, Inc.)
No Undisclosed Events or Circumstances. Except Since December 31, 2009, except as disclosed in the SEC Documents, since December 31, 2023, except for the consummation of the transactions contemplated herein, to the Company’s knowledgeFilings, no event or circumstance has occurred or exists with respect to the Company or its businesses, properties, prospects, operations or financial condition, whichthat, under applicable law, rule or regulation, requires public disclosure or announcement prior to the date hereof by the Company but which has not been so publicly announced or discloseddisclosed in the SEC Filings.
Appears in 2 contracts
Sources: Subscription Agreement (Yesdtc Holdings, Inc.), Subscription Agreement (Yesdtc Holdings, Inc.)
No Undisclosed Events or Circumstances. Except as disclosed in the SEC Documents, since December 31November 14, 20232013, except for the consummation of the transactions contemplated herein, to the Company’s knowledge, no event or circumstance has occurred or exists with respect to the Company or its businesses, properties, prospects, operations or financial condition, which, under applicable law, rule or regulation, requires public disclosure or announcement by the Company but which has not been so publicly announced or disclosed.
Appears in 2 contracts
Sources: Supplemental Stock Issuance Agreement (Fibrocell Science, Inc.), Supplemental Stock Issuance Agreement (Intrexon Corp)
No Undisclosed Events or Circumstances. Except as disclosed in the SEC Documents, since December 31, 2023, and except for the consummation of the transactions contemplated herein, since March 31, 2016, to the Company’s knowledge, no event or circumstance has occurred or exists with respect to the Company or its businesses, properties, prospects, operations or financial condition, which, under applicable law, rule or regulation, requires public disclosure or announcement by the Company but which has not been so publicly announced or disclosed.
Appears in 2 contracts
Sources: Stock Purchase Agreement (Oragenics Inc), Stock Purchase Agreement
No Undisclosed Events or Circumstances. Except as disclosed in the SEC Documents, since December 31October 5, 20232012, except for the consummation of the transactions contemplated herein, to the Company’s knowledge, no event or circumstance has occurred or exists with respect to the Company or its businesses, properties, prospects, operations or financial condition, which, under applicable law, rule or regulation, requires public disclosure or announcement by the Company but which has not been so publicly announced or disclosed.
Appears in 2 contracts
Sources: Supplemental Stock Issuance Agreement, Supplemental Stock Issuance Agreement (Fibrocell Science, Inc.)
No Undisclosed Events or Circumstances. Except as disclosed in the SEC Documents, since December 31June 30, 20232013, except for the consummation of the transactions contemplated herein, to the Company’s knowledge, no event or circumstance has occurred or exists with respect to the Company or its businesses, properties, prospects, operations or financial condition, which, under applicable law, rule or regulation, requires public disclosure or announcement by the Company but which has not been so publicly announced or disclosed.
Appears in 2 contracts
Sources: Stock Purchase and Issuance Agreement (Oragenics Inc), Stock Purchase and Issuance Agreement (Intrexon Corp)
No Undisclosed Events or Circumstances. Except as disclosed in the SEC Documents, since December 31, 20232021, except for the consummation of the transactions contemplated herein, to the Company’s knowledge, no event or circumstance has occurred or exists with respect to the Company or its businesses, properties, prospects, operations or financial condition, which, under applicable law, rule or regulation, requires public disclosure or announcement by the Company but which has not been so publicly announced or disclosed.
Appears in 2 contracts
Sources: Securities Purchase Agreement (Exicure, Inc.), Securities Purchase Agreement (Exicure, Inc.)
No Undisclosed Events or Circumstances. Except as disclosed in the SEC Commission Documents, since December 31September 30, 20232006, except for the consummation of the transactions contemplated herein, to the Company’s knowledge, no event or circumstance has occurred or exists with respect to the Company or its Subsidiary or their respective businesses, properties, prospects, operations or financial condition, which, under applicable law, rule or regulation, requires public disclosure or announcement by the Company but which has not been so publicly announced or disclosed.
Appears in 2 contracts
Sources: Stock Purchase Agreement (Halozyme Therapeutics Inc), Stock Purchase Agreement (Halozyme Therapeutics Inc)
No Undisclosed Events or Circumstances. Except as disclosed in the SEC Documents, since December 31, 20232012, except for the consummation of the transactions contemplated herein, to the Company’s knowledgeKnowledge, no event or circumstance has occurred or exists with respect to the Company or its businesses, properties, prospects, operations or financial condition, which, under applicable law, rule or regulationany Requirement of Law, requires public disclosure or announcement by the Company but which has not been so publicly announced or disclosed.
Appears in 1 contract
Sources: Series B Convertible Preferred Stock Purchase Agreement (Transgenomic Inc)
No Undisclosed Events or Circumstances. Except as disclosed in the SEC Documents, since December 31, 2023, and except for the consummation of the transactions contemplated herein, since March 31, 2017, to the Company’s knowledge, no event or circumstance has occurred or exists with respect to the Company or its businesses, properties, prospects, operations or financial condition, which, under applicable law, rule or regulation, requires public disclosure or announcement by the Company but which has not been so publicly announced or disclosed.
Appears in 1 contract
No Undisclosed Events or Circumstances. Except as disclosed in the SEC Commission Documents, since December 31, 20232006, except for the consummation of the transactions contemplated herein, to the Company’s knowledge, no event or circumstance has occurred or exists with respect to the Company or its Subsidiary or their respective businesses, properties, prospects, operations or financial condition, which, under applicable law, rule or regulation, requires public disclosure or announcement by the Company but which has not been so publicly announced or disclosed.
Appears in 1 contract
Sources: Stock Purchase Agreement (Halozyme Therapeutics Inc)
No Undisclosed Events or Circumstances. Except as disclosed in the SEC Documents, since Since December 31, 2023, except for the consummation of the transactions contemplated herein-------------------------------------- 2000, to the Company’s knowledge, 's knowledge no event or circumstance has occurred or exists with respect to the Company or its businesses, properties, prospects, operations or financial condition, whichthat, under applicable law, rule or regulation, requires public disclosure or announcement prior to the date hereof by the Company but which has not been so publicly announced or discloseddisclosed in the SEC Documents.
Appears in 1 contract
Sources: Common Stock Purchase Agreement (Hollis Eden Pharmaceuticals Inc /De/)
No Undisclosed Events or Circumstances. Except as disclosed in the SEC Documents, since December 31, 20232010, except for the consummation of the transactions contemplated herein, to the Company’s knowledgeKnowledge, no event or circumstance has occurred or exists with respect to the Company or its businesses, properties, prospects, operations or financial condition, which, under applicable law, rule or regulationany Requirement of Law, requires public disclosure or announcement by the Company but which has not been so publicly announced or disclosed.
Appears in 1 contract
Sources: Convertible Promissory Note Purchase Agreement (Transgenomic Inc)
No Undisclosed Events or Circumstances. Except as disclosed in the SEC Documents, since December March 31, 20232015, except for the consummation of the transactions contemplated herein, to the Company’s knowledge, no event or circumstance has occurred or exists with respect to the Company or its businesses, properties, prospects, operations or financial condition, which, under applicable law, rule or regulation, requires public disclosure or announcement by the Company but which has not been so publicly announced or disclosed.
Appears in 1 contract
Sources: Stock Issuance Agreement (Synthetic Biologics, Inc.)
No Undisclosed Events or Circumstances. Except as disclosed in the SEC Documents, since December 31, 20232009, except for the consummation of the transactions contemplated herein, to the Company’s knowledgeKnowledge, no event or circumstance has occurred or exists with respect to the Company or its businesses, properties, prospects, operations or financial condition, which, under applicable law, rule or regulationany Requirement of Law, requires public disclosure or announcement by the Company but which has not been so publicly announced or disclosed.
Appears in 1 contract
Sources: Series a Convertible Preferred Stock Purchase Agreement (Transgenomic Inc)
No Undisclosed Events or Circumstances. Except as disclosed in the SEC Commission Documents, since December March 31, 20232012, except for the consummation of the transactions contemplated herein, to the Company’s knowledge, no event or circumstance has occurred or exists with respect to the Company or its businesses, properties, prospects, operations or financial condition, which, under applicable law, rule or regulation, requires public disclosure or announcement by the Company but which has not been so publicly announced or disclosed.
Appears in 1 contract
No Undisclosed Events or Circumstances. Except as disclosed in the SEC Documents, since December 31, 2023, and except for the consummation of the transactions contemplated herein, since March 31, 2018, to the Company’s knowledge, no event or circumstance has occurred or exists with respect to the Company or its businesses, properties, prospects, operations or financial condition, which, under applicable law, rule or regulation, requires public disclosure or announcement by the Company but which has not been so publicly announced or disclosed.
Appears in 1 contract
Sources: Share Purchase Agreement (Youngevity International, Inc.)
No Undisclosed Events or Circumstances. Except as disclosed in the SEC Commission Documents, since December 31, 20232010, except for the consummation of the transactions contemplated herein, to the Company’s knowledge, no event or circumstance has occurred or exists with respect to the Company or its businesses, properties, prospects, operations or financial condition, which, under applicable law, rule or regulation, requires public disclosure or announcement by the Company but which has not been so publicly announced or disclosed.
Appears in 1 contract
Sources: Stock Purchase Agreement (Adeona Pharmaceuticals, Inc.)
No Undisclosed Events or Circumstances. Except as disclosed in the SEC Commission Documents, since December 31, 20232012, except for the consummation of the transactions contemplated herein, to the Company’s knowledge, no event or circumstance has occurred or exists with respect to the Company or its businesses, properties, prospects, operations or financial condition, which, under applicable law, rule or regulation, requires public disclosure or announcement by the Company but which has not been so publicly announced or disclosed.
Appears in 1 contract
No Undisclosed Events or Circumstances. Except as disclosed in the SEC Documents, since December 31, 2023, and except for the consummation of the transactions contemplated herein, since March 31, 2012, to the Company’s knowledge, no event or circumstance has occurred or exists with respect to the Company or its businesses, properties, prospects, operations or financial condition, which, under applicable law, rule or regulation, requires public disclosure or announcement by the Company but which has not been so publicly announced or disclosed.
Appears in 1 contract
No Undisclosed Events or Circumstances. Except as disclosed in the SEC Documents, since December 31, 2023, and except for the consummation of the transactions contemplated herein, since September 30, 2013, to the Company’s knowledge, no event or circumstance has occurred or exists with respect to the Company or its businesses, properties, prospects, operations or financial condition, which, under applicable law, rule or regulation, requires public disclosure or announcement by the Company but which has not been so publicly announced or disclosed.
Appears in 1 contract
No Undisclosed Events or Circumstances. Except as disclosed in the SEC Documents, since December 31, 20232014, except for the consummation of the transactions contemplated herein, to the Company’s knowledge, no event or circumstance has occurred or exists with respect to the Company or its businesses, properties, prospects, operations or financial condition, which, under applicable law, rule or regulation, requires public disclosure or announcement by the Company but which has not been so publicly announced or disclosed.
Appears in 1 contract
No Undisclosed Events or Circumstances. Except as disclosed in the SEC Disclosure Documents, since December 31, 20232022, except for the consummation of the transactions contemplated herein, to the Company’s knowledge, no event or circumstance has occurred or exists with respect to the Company or its businesses, properties, prospects, operations or financial condition, which, under applicable law, rule or regulation, requires public disclosure or announcement by the Company but which has not been so publicly announced or disclosed.
Appears in 1 contract
No Undisclosed Events or Circumstances. Except as disclosed in the SEC Documents, since December 31, 20232019, except for the consummation of the transactions contemplated herein, to the Company’s knowledge, no event or circumstance has occurred or exists with respect to the Company or its businesses, properties, prospects, operations or financial condition, which, under applicable law, rule or regulation, requires public disclosure or announcement by the Company but which has not been so publicly announced or disclosed.
Appears in 1 contract
No Undisclosed Events or Circumstances. Except as disclosed in the SEC Documents, since December 31June 30, 20232022, except for the consummation of the transactions contemplated herein, to the Company’s knowledge, no event or circumstance has occurred or exists with respect to the Company or its businesses, properties, prospects, operations or financial condition, which, under applicable law, rule or regulation, requires public disclosure or announcement by the Company but which has not been so publicly announced or disclosed.
Appears in 1 contract
Sources: Securities Purchase Agreement (Taysha Gene Therapies, Inc.)
No Undisclosed Events or Circumstances. Except as disclosed in the SEC Documents, since December 31, 20232017, except for the consummation of the transactions contemplated herein, to the Company’s knowledge, no event or circumstance has occurred or exists with respect to the Company or its businesses, properties, prospects, operations or financial condition, which, under applicable law, rule or regulation, requires public disclosure or announcement by the Company but which has not been so publicly announced or disclosed.
Appears in 1 contract
Sources: Securities Purchase Agreement (Ziopharm Oncology Inc)
No Undisclosed Events or Circumstances. Except as disclosed in the SEC Documents, since December 31, 2023, and except for the consummation of the transactions contemplated herein, since December 31, 2011, to the Company’s knowledge, no event or circumstance has occurred or exists with respect to the Company or its businesses, properties, prospects, operations or financial condition, which, under applicable law, rule or regulation, requires public disclosure or announcement by the Company but which has not been so publicly announced or disclosed.
Appears in 1 contract
Sources: Stock Purchase Agreement (Synthetic Biologics, Inc.)